Cardiovascular disease remains a leading cause of death and morbidity in the United States despite substantial gains in diagnostics, prevention, and treatment. The 2014 URMC Cardiology for Clinicians Spring Symposium plans to go well beyond literature and guideline reviews to provide seasoned expert judgment and recommendations of key advances and state of the art cardiovascular care that clinicians require and their patients expect.
The program begins with an update on the clinical evaluation of cardiovascular risk with concise overview of the recently revised national guidelines of hypertension and lipids. This topic is covered in greater depth in small group interactive format during the afternoon workshop in preventive cardiology. Next, critical review and recommendations of the value of the new target specific oral anticoagulants compared to warfarin for management of non-valvular atrial fibrillation will be given. Expert recommendations for interventional management of patent foramen ovale based on recent randomized trials will be discussed. In depth discussion of the Evaluation and Treatment of Pulmonary Hypertension with both case examples and in depth review of pathophysiology will be provided.
Salient issues and complexities of women’s heart health will be discussed by Dr. Hanna Mieszczanska who will present “Fixing a Woman’s Broken Heart” which draws from the wisdom of her recently published multi-authored book on this topic. URMC heart failure experts will review recommendations for understanding the practical pathophysiology of heart failure to provide insights in heart failure management that have important implications for avoiding costly readmissions to hospital by going well beyond basic clinical practice of salt and water management.
After lunch, the small group workshops in noninvasive cardiac imaging, preventive cardiology, and clinical cardiovascular roundtable will permit greater interaction of attendees and URMC faculty as the best cardiac imaging cases in nuclear cardiology (SPECT and PET), advances in the imaging of the morbidly obese with CZT SPECT MPI, and cardiac MRI are presented. The state of the art of cardiac rehabilitation, appropriate patient selection for electrophysiology study, and the detection, risk stratification and consideration of treatment options for patients with peripheral arterial disease will be discussed by vascular surgeon Adam Doyle.
The concluding Keynote Address will be given by Dr. Leway Chen, Medical Director of Cardiac Transplantation who will review the state of the art of this field and share key lessons learned with the highly successful URMC cardiac transplantation program he has co-founded.
Presented by both community- and world renowned experts in their fields, the 2014 URMC Cardiology for Clinicians Spring Symposium is designed to provide the clinician who needs to know a substantive and interactive learning experience to enhance understanding of the year’s best clinical cases and state of the art of major developments in the field of cardiovascular medicine.
At the conclusion of this program, participants should be able to:
- Describe the benefits, costs and value of the new oral target specific anticoagulants compared to warfarin in the treatment of stroke risk in atrial fibrillation
- Describe state of the art interventional approaches to treatment of PFO
- Understand the changes to recommendations in treatment of hypertension and lipid management.
- Discuss advances in women’s heart health
- Discuss advances in diagnosis and prognosis of morbidly obese patients with CZT SPECT nuclear cardiology imaging
- Discuss diagnosis and treatment strategies of patients with pulmonary hypertension
- Recognize patients in your practice who are potential candidates for cardiac transplantation surgery